Atlas Trials

NEC Bio B.V

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch NEC Bio B.V

RecordFirmDate
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer (NCT06631092)NEC Bio B.V2024-11-20
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy in Patients With Solid Tumors (NCT06631079)NEC Bio B.V2024-10-07

Track NEC Bio B.V automatically

Every clearance here is in the API, with alerts when new ones post.